Christian Cahlin

Indications and results of liver transplantation in patients with neuroendocrine tumors.

[Treatment of patients with liver metastases from colorectal cancer. More patients can benefit from the treatment!].

Liver transplantation for treatment of metastatic neuroendocrine tumors.

Impressive regression of primary liver cancer after treatment with sirolimus.

The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors.

A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma.

Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors.

[Liver transplantation in metastatic neuroendocrine tumors. Symptom-free intervals and cure possible].

Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer.

Isolated hepatic perfusion for liver metastases of malignant melanoma.

Growth associated proteins in tumor cells and stroma related to disease progression of colon cancer accounting for tumor tissue PGE2 content.

Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial.